Arphra/Issuer/AMGN

AMGN

Amgen Inc.

HealthcareDrug Manufacturers - GeneralUSUSD

$329.36

-0.77%LiveJun 02, 2026

AI Brief

Market cap

$177.76B

52w range

267.83 – 391.29

P / E

—

EPS

—

Volume

741.71K

Revenue · FY

$36.74B

+9.92% YoY

Explain this page

Arphra AIPlain-English read on Amgen Inc.’s valuation

Total filings

Last ~200

YTD

2026

8-Ks · 12mo

Current reports

Last filing

—

AI · Disclosure analysis

Arphra AI

Click Analyze filings to have Arphra AI review the last 80 SEC filings for AMGN and return: a one-paragraph summary of recent disclosure activity, 3-5 thematic patterns, 3-5 notable individual filings worth flagging, and 2-3 watch items.

M&A activity

3DB

Whole-company transactions where AMGN is acquirer or target.

Date	Role	Counterparty	Filing
Apr 23, 2004	Acquirer	Tularik	SEC →
Jan 31, 2002	Acquirer	Immunex	SEC →
Nov 03, 2000	Acquirer	Kinetix	SEC →

No filings in last 5 years.

Form-type mix

No data.

All 8-K · Current reports 10-K · 10-Q Proxy & ownership Registration Other

0 filingsDB · sec_filings

Filed	Accepted	Form	Description	Link
No filings in this group.